The Drug Controller General of India (DCGI) plans to hold walk-in meetings with stakeholders to improve the ease of doing business in India. Starting on February 20, these meetings will take place every Tuesday and Thursday at the CDSCO Headquarters. The DCGI, responsible for drug approval, clinical trials, drug standards, imported drug quality control, and State Drug Control Organization coordination, aims to hear complaints, grievances, and suggestions for swift resolution.
While the combination, called fixed-dose combination, was already under scanner for being “irrational”, the government committee had approved it after finding reasonable evidence
India Business News: A government report reveals that more than 50 companies in India manufacturing cough syrups have failed quality tests. Out of 2,104 test reports, 128